SCHEMBL8667950

SCHEMBL8667950

CC(=O)Nc1cc2c(cc1Br)CC(C(C)C(=O)O)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ALDH1A1 P00352 3/20 0.35
RXFP1 Q9HBX9 1/20 0.34
KDM4E B2RXH2 4/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
ALOX15 P16050 1/20 0.33
BRPF1 P55201 1/20 0.32
HTT P42858 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAOA P21397 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11985027 0.79 CA1 (0.43) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL29575116 0.79 CA1 (0.45) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL433839 0.79 CA1 (0.45) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL19995817 0.79 CA1 (0.45) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL8668643 0.77 CA1 (0.50) CA1CA2CA9RXFP1
SCHEMBL8669491 0.76 CYP1A2 (0.47) ALDH1A1KDM4ECYP1A2MAPTMEN1
SCHEMBL8669479 0.74 KDM4E (0.33) KDM4EMAPT
SCHEMBL8699267 0.73 CA1 (0.38) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL18750435 0.71 CA1 (0.56) CA1CA2CA9ALDH1A1RXFP1
SCHEMBL16769416 0.69 CA1 (0.45) CA1CA2CA9ALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed